Stephen Caldwell (Rohit Loomba, R Loomba)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 105

Top Venues

Alimentary pharmacology & therapeutics

Hepatology (Baltimore, Md.)

Gut

Nature reviews. Gastroenterology & hepatology

University of California San Diego School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California San Diego School of Medicine

United States

Professor of Medicine :: NAFLD Research Center, Department of Medicine

Publications

Arun J Sanyal, Sudha Shankar, Katherine Yates, James Bolognese, Erica Daly, Clayton Dehn, Brent A Neuschwander-Tetri, Kris Kowdley, Raj Vuppalanchi, Cynthia A Behling, James Tonascia, Anthony Samir, Claude B Sirlin, Sarah Sherlock, Kathryn Fowler, Helen Heymann, Tania Kamphaus, Stephen Caldwell, Roberto A Calle
The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis. Research square (2023)
Daniel Q Huang, Norah A Terrault, Frank Tacke, Lise Lotte Gluud, Marco Arrese, Elisabetta Bugianesi, Stephen Caldwell
Global epidemiology of cirrhosis - aetiology, trends and predictions. Nature reviews. Gastroenterology & hepatology (2023)
A-Na Liu, Cui-Fang Xu, Ya-Ru Liu, Dan-Qin Sun, Ling Jiang, Liang-Jie Tang, Pei-Wu Zhu, Sui-Dan Chen, Wen-Yue Liu, Xiao-Dong Wang, Giovanni Targher, Christopher D Byrne, Vincent Wai-Sun Wong, Junfen Fu, Ming-Ming Su, Stephen Caldwell, Ming-Hua Zheng, Yan Ni
Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease. Alimentary pharmacology & therapeutics (2023)
Nabil Noureddin, Veeral H Ajmera, Jaclyn Bergstrom, Richele Bettencourt, Daniel Q Huang, Harris Siddiqi, Abdul M Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Hirokazu Takahashi, Ramzan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Stephen Caldwell
MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analyses. Alimentary pharmacology & therapeutics (2023)
Stephen Caldwell, Arun J Sanyal, Kris V Kowdley, Deepak L Bhatt, Rohit L Loomba, Juan Pablo Frias, Pierre Bedossa, Stephen A Harrison, Donald Lazas, Robert Barish, Mildred D Gottwald, Shibao Feng, Germaine D Agollah, Cynthia L Hartsfield, Hank Mansbach, Maya Margalit, Manal F Abdelmalek
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH. The New England journal of medicine (2023)
Daniel Q Huang, Kai En Chan, Caitlyn Tan, Rebecca Wenling Zeng, Benjamin Koh, Elden Yen Hng Ong, Charlotte Chung Hui Ong, Christen En Ya Ong, Darren J H Tan, Wen Hui Lim, Elina Cho, Eunice X X Tan, Margaret L P Teng, Cheng-Han Ng, Benjamin Nah, Mei Chin Lim, Mark Dhinesh Muthiah, Virginia C Clark, Stephen Caldwell
Meta-analysis: Prevalence of significant or advanced fibrosis in adults with alpha-1-antitrypsin deficiency. Alimentary pharmacology & therapeutics (2023)
Daniel Q Huang, Kai En Chan, Caitlyn Tan, Rebecca Wenling Zeng, Benjamin Koh, Elden Yen Hng Ong, Charlotte Chung Hui Ong, Christen En Ya Ong, Darren J H Tan, Wen Hui Lim, Elina Cho, Eunice X X Tan, Margaret L P Teng, Cheng-Han Ng, Benjamin Nah, Mei Chin Lim, Mark Dhinesh Muthiah, Virginia C Clark, Stephen Caldwell
Meta-analysis: Prevalence of significant or advanced fibrosis in adults with alpha-1-antitrypsin deficiency. Alimentary pharmacology & therapeutics (2023)
Arun J Sanyal, Sudha S Shankar, Katherine P Yates, James Bolognese, Erika Daly, Clayton A Dehn, Brent A Neuschwander-Tetri, Kris Kowdley, Raj K Vuppalanchi, Cynthia Behling, James Tonascia, Anthony E Samir, Claude B Sirlin, Sarah P Sherlock, Kathryn Fowler, Helen Heymann, Tania N Kamphaus, Stephen Caldwell, Roberto A Calle
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis. Nature medicine (2023)
Daniel Q Huang, Amit G Singal, Fasiha Kanwal, Pietro Lampertico, Maria Buti, Claude B Sirlin, Mindie H Nguyen, Stephen Caldwell
Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology. Nature reviews. Gastroenterology & hepatology (2023)
Mary E Rinella, Mohammad Shadab Siddiqui, Manal F Abdelmalek, Stephen Caldwell
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) (2023)
Rebecca W Zeng, Jie Ning Yong, Darren J H Tan, Clarissa E Fu, Wen Hui Lim, Jieling Xiao, Kai En Chan, Caitlyn Tan, Xin Lei Goh, Douglas Chee, Nicholas Li-Xun Syn, Eunice X Tan, Mark Dhinesh Muthiah, Cheng-Han Ng, Nobuharu Tamaki, Sung Won Lee, Beom Kyung Kim, Mindie H Nguyen, Stephen Caldwell, Daniel Q Huang
Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin. Alimentary pharmacology & therapeutics 57 (6) (2023)
Suzanne Sharpton, Kuangda Shan, Ricki Bettencourt, Miryoung Lee, Joseph B McCormick, Susan P Fisher-Hoch, Stephen Caldwell
Prevalence and factors associated with liver fibrosis among first-degree relatives of Mexican Americans with hepatocellular carcinoma. Alimentary pharmacology & therapeutics 57 (4) (2023)
Daniel Q Huang, Norah A Terrault, Frank Tacke, Lise Lotte Gluud, Marco Arrese, Elisabetta Bugianesi, Stephen Caldwell
Global epidemiology of cirrhosis - aetiology, trends and predictions. Nature reviews. Gastroenterology & hepatology (2023)
Beom Kyung Kim, Nicole Bernstein, Daniel Q Huang, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Jinho Jung, Khang Nguyen, Leyna Nguyen, Tracy Le, Egbert Madamba, Lisa Richards, Mark A Valasek, Cynthia Behling, Claude B Sirlin, Hirokazu Takahashi, Stephen Caldwell
Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD. Alimentary pharmacology & therapeutics (2023)
Selena Z Kuo, Stephen Caldwell
Editorial: Can liver fat quantification stratify cardiovascular risk in type 2 diabetes? Authors' reply. Alimentary pharmacology & therapeutics 58 (10) (2023)
Arun J Sanyal, Sudha Shankar, Katherine Yates, James Bolognese, Erica Daly, Clayton Dehn, Brent A Neuschwander-Tetri, Kris Kowdley, Raj Vuppalanchi, Cynthia A Behling, James Tonascia, Anthony Samir, Claude B Sirlin, Sarah Sherlock, Kathryn Fowler, Helen Heymann, Tania Kamphaus, Stephen Caldwell, Roberto A Calle
The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis. Research square (2023)
Rebecca W Zeng, Jie Ning Yong, Darren J H Tan, Clarissa E Fu, Wen Hui Lim, Jieling Xiao, Kai En Chan, Caitlyn Tan, Xin Lei Goh, Douglas Chee, Nicholas Li-Xun Syn, Eunice X Tan, Mark Dhinesh Muthiah, Cheng-Han Ng, Nobuharu Tamaki, Sung Won Lee, Beom Kyung Kim, Mindie H Nguyen, Stephen Caldwell, Daniel Q Huang
Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin. Alimentary pharmacology & therapeutics (2023)
Riha Vaidya, Joseph M Unger, Stephen Caldwell, Jessica P Hwang, Rashmi Chugh, Monica A Tincopa, Kathryn B Arnold, Dawn L Hershman, Scott D Ramsey
Universal Viral Screening of Newly Diagnosed Cancer Patients in the United States: A Cost Efficiency Evaluation. Cancer research communications (2023)
Suzanne Sharpton, Kuangda Shan, Ricki Bettencourt, Miryoung Lee, Joseph B McCormick, Susan P Fisher-Hoch, Stephen Caldwell
Prevalence and factors associated with liver fibrosis among first-degree relatives of Mexican Americans with hepatocellular carcinoma. Alimentary pharmacology & therapeutics 57 (4) (2023)
Elina En Li Cho, Chong Zhe Ang, Jingxuan Quek, Clarissa Elysia Fu, Lincoln Kai En Lim, Zane En Qi Heng, Darren Jun Hao Tan, Wen Hui Lim, Jie Ning Yong, Rebecca Zeng, Douglas Chee, Benjamin Nah, Cosmas Rinaldi Adithya Lesmana, Aung Hlaing Bwa, Khin Maung Win, Claire Faulkner, Majd B Aboona, Mei Chin Lim, Nicholas Syn, Anand V Kulkarni, Hiroyuki Suzuki, Hirokazu Takahashi, Nobuharu Tamaki, Karn Wijarnpreecha, Daniel Q Huang, Mark Dhinesh Muthiah, Cheng-Han Ng, Stephen Caldwell
Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut (2023)
A-Na Liu, Cui-Fang Xu, Ya-Ru Liu, Dan-Qin Sun, Ling Jiang, Liang-Jie Tang, Pei-Wu Zhu, Sui-Dan Chen, Wen-Yue Liu, Xiao-Dong Wang, Giovanni Targher, Christopher D Byrne, Vincent Wai-Sun Wong, Junfen Fu, Ming-Ming Su, Stephen Caldwell, Ming-Hua Zheng, Yan Ni
Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease. Alimentary pharmacology & therapeutics 57 (8) (2023)
Sung Won Lee, Daniel Q Huang, Ricki Bettencourt, Veeral H Ajmera, Monica A Tincopa, Nabil Noureddin, Maral Amangurbanova, Harris Siddiqi, Egbert Madamba, Abdul M Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Hirokazu Takahashi, Masato Yoneda, Ramzan Idilman, Mesut Gumussoy, Digdem Kuru Oz, Ayse Erden, Stephen Caldwell
Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality. Alimentary pharmacology & therapeutics (2023)
Suzanne Sharpton, Kuangda Shan, Ricki Bettencourt, Miryoung Lee, Joseph B McCormick, Susan P Fisher-Hoch, Stephen Caldwell
Prevalence and factors associated with liver fibrosis among first-degree relatives of Mexican Americans with hepatocellular carcinoma. Alimentary pharmacology & therapeutics 57 (4) (2023)
Daniel Q Huang, Stephen Caldwell
Editorial: Will MRI-PDFF become the new standard for steatosis assessment in NAFLD? Authors' reply. Alimentary pharmacology & therapeutics 58 (3) (2023)
Selena Z Kuo, Sandra Cepin, Jaclyn Bergstrom, Harris Siddiqi, Jinho Jung, Scarlett Lopez, Daniel Q Huang, Pam Taub, Maral Amangurbanova, Stephen Caldwell
Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes. Alimentary pharmacology & therapeutics (2023)
Rebecca W Zeng, Jie Ning Yong, Darren J H Tan, Clarissa E Fu, Wen Hui Lim, Jieling Xiao, Kai En Chan, Caitlyn Tan, Xin Lei Goh, Douglas Chee, Nicholas Li-Xun Syn, Eunice X Tan, Mark Dhinesh Muthiah, Cheng-Han Ng, Nobuharu Tamaki, Sung Won Lee, Beom Kyung Kim, Mindie H Nguyen, Stephen Caldwell, Daniel Q Huang
Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin. Alimentary pharmacology & therapeutics 57 (6) (2023)
A-Na Liu, Cui-Fang Xu, Ya-Ru Liu, Dan-Qin Sun, Ling Jiang, Liang-Jie Tang, Pei-Wu Zhu, Sui-Dan Chen, Wen-Yue Liu, Xiao-Dong Wang, Giovanni Targher, Christopher D Byrne, Vincent Wai-Sun Wong, Junfen Fu, Ming-Ming Su, Stephen Caldwell, Ming-Hua Zheng, Yan Ni
Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease. Alimentary pharmacology & therapeutics 57 (8) (2023)
Daniel Q Huang, Kai En Chan, Caitlyn Tan, Rebecca Wenling Zeng, Benjamin Koh, Elden Yen Hng Ong, Charlotte Chung Hui Ong, Christen En Ya Ong, Darren J H Tan, Wen Hui Lim, Elina Cho, Eunice X X Tan, Margaret L P Teng, Cheng-Han Ng, Benjamin Nah, Mei Chin Lim, Mark Dhinesh Muthiah, Virginia C Clark, Stephen Caldwell
Meta-analysis: Prevalence of significant or advanced fibrosis in adults with alpha-1-antitrypsin deficiency. Alimentary pharmacology & therapeutics (2023)
Suzanne R Sharpton, Stephen Caldwell
Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC. Hepatology (Baltimore, Md.) (2023)
Suzanne Sharpton, Kuangda Shan, Ricki Bettencourt, Miryoung Lee, Joseph B McCormick, Susan P Fisher-Hoch, Stephen Caldwell
Original Article: prevalence and factors associated with liver fibrosis among first-degree relatives of Mexican Americans with hepatocellular carcinoma. Alimentary pharmacology & therapeutics (2023)
Arun J Sanyal, Sudha Shankar, Katherine Yates, James Bolognese, Erica Daly, Clayton Dehn, Brent A Neuschwander-Tetri, Kris Kowdley, Raj Vuppalanchi, Cynthia A Behling, James Tonascia, Anthony Samir, Claude B Sirlin, Sarah Sherlock, Kathryn Fowler, Helen Heymann, Tania Kamphaus, Stephen Caldwell, Roberto A Calle
The Nimble Stage 1 Study Validates Diagnostic Circulating Biomarkers for Nonalcoholic Steatohepatitis. Research square (2023)
Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Siddharth Singh, Stephen Caldwell
Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 55 (8) (2022)
Daniel Q Huang, Kathryn J Fowler, Joy Liau, Guilherme M Cunha, Ashley L Louie, Julie Y An, Ricki Bettencourt, Jinho Jung, Zachary Gitto, Christie Hernandez, Scarlett J Lopez, Hersh Gupta, Claude B Sirlin, Robert M Marks, Stephen Caldwell
Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study. Alimentary pharmacology & therapeutics 55 (7) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Issacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2022)
Matti O Ruuskanen, Fredrik O Åberg, Ville T Männistö, Aki Samuli Havulinna, Guillaume Méric, Yang Liu, Stephen Caldwell, Yoshiki Vázquez-Baeza, Anupriya Tripathi, Liisa M Valsta, Michael Inouye, Pekka Jousilahti, Veikko V Salomaa, Mohit Jain, Rob Knight, Leo Lahti, Teemu J Niiranen
Links between gut microbiome composition and fatty liver disease in a large population sample. Gut microbes 13 (1) (2022)
Daniel Q Huang, Philippe Mathurin, Helena Cortez-Pinto, Stephen Caldwell
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nature reviews. Gastroenterology & hepatology (2022)
Daniel Q Huang, Stephen Caldwell
Editorial: screening for hepatocellular carcinoma in NAFLD cirrhosis-towards abbreviated MRI alternative in patients with obesity? Authors' reply. Alimentary pharmacology & therapeutics 55 (9) (2022)
Suzanne R Sharpton, Tae Gyu Oh, Egbert Madamba, Chenjingyi Wang, Ruth T Yu, Annette R Atkins, Tao Huan, Michael Downes, Ronald M Evans, Stephen Caldwell
Gut metagenome-derived signature predicts hepatic decompensation and mortality in NAFLD-related cirrhosis. Alimentary pharmacology & therapeutics 56 (10) (2022)
Marybeth A Nedrud, Mohammad Chaudhry, Michael S Middleton, Cynthia A Moylan, Reginald Lerebours, Sheng Luo, Alfredo Farjat, Cynthia Guy, Stephen Caldwell, Manal F Abdelmalek, Claude B Sirlin, Mustafa R Bashir
MRI Quantification of Placebo Effect in Nonalcoholic Steatohepatitis Clinical Trials. Radiology (2022)
Veeral Ajmera, Khang Nguyen, Nobuharu Tamaki, Suzanne R Sharpton, Ricki Bettencourt, Stephen Caldwell
Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease. Therapeutic advances in gastroenterology 15 (2022)
Cheng-Han Ng, Wen Hui Lim, Yip Han Chin, Jie Ning Yong, Rebecca Wenling Zeng, Kai En Chan, Darren Jun Hao Tan, Clarissa Elysia Fu, Ansel Shao Pin Tang, Lay Hoon Goh, Kamala Devi, Nicholas W S Chew, Lung-Yi Loey Mak, Nobuharu Tamaki, Daniel Q Huang, Mazen Noureddin, Mohammad Shadab Siddiqui, Stephen Caldwell, Arun J Sanyal, Mark Dhinesh Muthiah
Living in the non-alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives. Alimentary pharmacology & therapeutics 56 (4) (2022)
Stephen Caldwell, Daniel Q Huang, Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew Billin, Ryan S Huss, Chuhan Chung, Zachary Goodman, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gómez, Manal F Abdelmalek, Andrew Muir, Nezam Afdhal, Jaime Bosch, Stephen Harrison, Zobair M Younossi, Robert P Myers
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. Gut 72 (3) (2022)
Cheng Han Ng, Jieling Xiao, Wen Hui Lim, Yip Han Chin, Jie Ning Yong, Darren Jun Hao Tan, Phoebe Tay, Nicholas Syn, Roger Foo, Mark Chan, Nicholas Chew, Eunice Xx Tan, Daniel Q Huang, Yock Young Dan, Nobuharu Tamaki, Mohammad Shadab Siddiqui, Arun J Sanyal, Stephen Caldwell, Mazen Noureddin, Mark Dhinesh Muthiah
Placebo effect on progression and regression in NASH: Evidence from a meta-analysis. Hepatology (Baltimore, Md.) 75 (6) (2022)
Rish K Pai, Vipul Jairath, Malcolm Hogan, Guangyong Zou, Oyedele A Adeyi, Quentin Mark Anstee, Bashar A Aqel, Cynthia Behling, Elizabeth J Carey, Andrew D Clouston, Kathleen E Corey, Brian G Feagan, David E Kleiner, Christopher Ma, Stefanie C McFarlane, Mazen Noureddin, Vlad Ratziu, Mark A Valasek, Zobair M Younossi, Stephen A Harrison, Stephen Caldwell
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score. Hepatology (Baltimore, Md.) 76 (4) (2022)
Elliot B Tapper, Nneka N Ufere, Daniel Q Huang, Stephen Caldwell
Review article: current and emerging therapies for the management of cirrhosis and its complications. Alimentary pharmacology & therapeutics 55 (9) (2022)
Danielle Brandman, Marie Boyle, McPherson Stuart, Mark L Van Natta, Arun J Sanyal, Kris Kowdley, Brent Neuschwander-Tetri, Naga Chalasani, Manal F Abdelmalek, Norah A Terrault, Art McCullough, Ricki Bettencourt, Cyrielle Caussy, David E Kleiner, Cynthia Behling, James Tonascia, Quentin Mark Anstee, Stephen Caldwell
Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' reply. Alimentary pharmacology & therapeutics 56 (1) (2022)
Danielle Brandman, Marie Boyle, McPherson Stuart, Mark L Van Natta, Arun J Sanyal, Kris Kowdley, Brent Neuschwander-Tetri, Naga P Chalasani, Manal F Abdelmalek, Norah A Terrault, Art McCullough, Ricki Bettencourt, Cyrielle Caussy, David E Kleiner, Cynthia Behling, James Tonascia, Quentin Mark Anstee, Stephen Caldwell, null null
Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD). Alimentary pharmacology & therapeutics 55 (11) (2022)
Jinho Jung, Aiguo Han, Egbert Madamba, Ricki Bettencourt, Rohan R Loomba, Andrew S Boehringer, Michael P Andre, John W Erdman, William D O'Brien, Kathryn J Fowler, Claude B Sirlin, Stephen Caldwell
Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD. Radiology 304 (1) (2022)
Arun J Sanyal, Sudha S Shankar, Roberto A Calle, Anthony E Samir, Claude B Sirlin, Sarah P Sherlock, Stephen Caldwell, Kathryn J Fowler, Clayton A Dehn, Helen Heymann, Tania N Kamphaus
Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis: the FNIH NIMBLE project. Nature medicine 28 (3) (2022)
Stephen Caldwell, Daniel Q Huang, Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew Billin, Ryan S Huss, Chuhan Chung, Zachary Goodman, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gómez, Manal F Abdelmalek, Andrew Muir, Nezam Afdhal, Jaime Bosch, Stephen Harrison, Zobair M Younossi, Robert P Myers
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. Gut 72 (3) (2022)
Maral Amangurbanova, Daniel Q Huang, Stephen Caldwell
Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLD. Alimentary pharmacology & therapeutics (2022)
Sílvia Vilarinho, Veeral H Ajmera, Melanie Zheng, Stephen Caldwell
Emerging Role of Genomic Analysis in Clinical Evaluation of Lean Individuals With NAFLD. Hepatology (Baltimore, Md.) 74 (4) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Stephen Caldwell, Daniel Q Huang, Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew Billin, Ryan S Huss, Chuhan Chung, Zachary Goodman, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gómez, Manal F Abdelmalek, Andrew Muir, Nezam Afdhal, Jaime Bosch, Stephen Harrison, Zobair M Younossi, Robert P Myers
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. Gut 72 (3) (2022)
Phoebe Wen Lin Tay, Cheng Han Ng, Snow Yunni Lin, Yip Han Chin, Jieling Xiao, Wen Hui Lim, Sze Yinn Lim, Clarissa Elysia Fu, Kai En Chan, Jingxuan Quek, Darren Jun Hao Tan, Nicholas Chew, Nicholas Syn, Taisei Keitoku, Nobuharu Tamaki, Mohammad Shadab Siddiqui, Mazen Noureddin, Mark Muthiah, Daniel Q Huang, Stephen Caldwell
Placebo Adverse Events in Non-alcoholic Steatohepatitis Clinical Trials: A Pooled Analysis of 2,944 Participants. The American journal of gastroenterology (2022)
Cheng-Han Ng, Mark Dhinesh Muthiah, Jieling Xiao, Yip Han Chin, Grace Lim, Wen Hui Lim, Phoebe Tay, Darren Jun Hao Tan, Jie Ning Yong, Xin-Hui Pan, Jeffery Wei Heng Koh, Nicholas Chew, Nicholas Li-Xun Syn, Eunice Tan, Daniel Q Huang, Mohammad Shadab Siddiqui, Stephen Caldwell, Arun J Sanyal, Mazen Noureddin
Meta-analysis: analysis of mechanistic pathways in the treatment of non-alcoholic steatohepatitis. Evidence from a Bayesian network meta-analysis. Alimentary pharmacology & therapeutics 55 (9) (2022)
Jean-François Dufour, Quentin Mark Anstee, Elisabetta Bugianesi, Stephen Harrison, Stephen Caldwell, Valerie Paradis, Herbert Tilg, Vincent Wai-Sun Wong, Shira Zelber-Sagi
Current therapies and new developments in NASH. Gut (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Stephen Caldwell, Daniel Q Huang, Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew Billin, Ryan S Huss, Chuhan Chung, Zachary Goodman, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gómez, Manal F Abdelmalek, Andrew Muir, Nezam Afdhal, Jaime Bosch, Stephen Harrison, Zobair M Younossi, Robert P Myers
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. Gut 72 (3) (2022)
Darren Jun Hao Tan, Veronica Wendy Setiawan, Cheng-Han Ng, Wen Hui Lim, Mark D Muthiah, Eunice X Tan, Yock Young Dan, Lewis R Roberts, Stephen Caldwell, Daniel Q Huang
Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH. Hepatology (Baltimore, Md.) (2022)
Vlad Ratziu, L de Guevara, R Safadi, F Poordad, F Fuster, J Flores-Figueroa, M Arrese, Anna L Fracanzani, D Ben Bashat, K Lackner, T Gorfine, S Kadosh, R Oren, M Halperin, L Hayardeny, Stephen Caldwell, Scott L Friedman, null null, Arun J Sanyal
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial. Nature medicine 27 (10) (2021)
Mayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, Kento Inada, Sakura Kirino, Koji Yamashita, Yuka Hayakawa, Leona Osawa, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Yuka Takahashi, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Stephen Caldwell, Nobuyuki Enomoto, Namiki Izumi
Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality. Alimentary pharmacology & therapeutics 55 (3) (2021)
Anne Flint, Grit Andersen, Paul Hockings, Leona Plum-Mörschel, Stephen Caldwell
Editorial: evolution of GLP-1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity - authors' reply. Alimentary pharmacology & therapeutics 54 (11-12) (2021)
Michelle T Long, Xiaoyu Zhang, Hanfei Xu, Ching-Ti Liu, Kathleen E Corey, Raymond T Chung, Stephen Caldwell, Emelia J Benjamin
Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study. Hepatology (Baltimore, Md.) 73 (2) (2021)
Veeral Ajmera, Amy Liu, Ricki Bettencourt, Debanjan Dhar, Lisa Richards, Stephen Caldwell
The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography. Alimentary pharmacology & therapeutics 54 (1) (2021)
Jeffrey Victor Lazarus, Henry E Mark, Quentin Mark Anstee, Juan Pablo Arab, Rachel L Batterham, Laurent Castera, Helena Cortez-Pinto, Javier Crespo, Kenneth Cusi, M Ashworth Dirac, Sven M Francque, Jacob George, Hannes Hagström, Terry T K Huang, Mona H Ismail, Achim Kautz, Shiv Kumar Sarin, Stephen Caldwell, Veronica Miller, Philip N Newsome, Michael Ninburg, Ponsiano Ocama, Vlad Ratziu, Mary Rinella, Diana Romero, Manuel Romero, Jörn Markus Schattenberg, Emmanuel A Tsochatzis, Luca Valenti, Vincent Wai-Sun Wong, Yusuf Yilmaz, Zobair M Younossi, Shira Zelber-Sagi, null null
Advancing the global public health agenda for NAFLD: a consensus statement. Nature reviews. Gastroenterology & hepatology (2021)
Carlos Lago-Hernandez, Nghia H Nguyen, Rohan Khera, Stephen Caldwell, Sumeet K Asrani, Siddharth Singh
Financial Hardship From Medical Bills Among Adults With Chronic Liver Diseases: National Estimates From the United States. Hepatology (Baltimore, Md.) 74 (3) (2021)
Nobuharu Tamaki, Nagambika Munaganuru, Jinho Jung, Aed Qas Yonan, Rohan R Loomba, Richele Bettencourt, Veeral Ajmera, Mark A Valasek, Cynthia Behling, Claude B Sirlin, Stephen Caldwell
Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease. Gut (2021)
Debanjan Dhar, Stephen Caldwell
Emerging Metabolic and Transcriptomic Signature of PNPLA3-Associated NASH. Hepatology (Baltimore, Md.) 73 (4) (2021)
Xiao-Jing Zhang, Zhi-Gang She, Junyong Wang, Dating Sun, Li-Jun Shen, Hui Xiang, Xu Cheng, Yan-Xiao Ji, Yong-Ping Huang, Peng-Long Li, Xia Yang, Yanjie Cheng, Jun-Peng Ma, Hai-Ping Wang, Yufeng Hu, Fengjiao Hu, Song Tian, Han Tian, Peng Zhang, Guang-Nian Zhao, Lin Wang, Man-Li Hu, Qin Yang, Li-Hua Zhu, Jingjing Cai, Juan Yang, Xin Zhang, Xin-Liang Ma, Qingbo Xu, Rhian M Touyz, Peter P Liu, Stephen Caldwell, Yibin Wang, Hong Liang Li
Multiple omics study identifies an interspecies conserved driver for nonalcoholic steatohepatitis. Science translational medicine 13 (624) (2021)
Anne Flint, Grit Andersen, Paul Hockings, Lars Johansson, Anni Morsing, Mads Sundby Palle, Thomas Vogl, Stephen Caldwell, Leona Plum-Mörschel
Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging. Alimentary pharmacology & therapeutics 54 (9) (2021)
Jung Gil Park, Jinho Jung, Stephen Caldwell
Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non-alcoholic fatty liver disease-simply associated or more complicated? Authors' reply. Alimentary pharmacology & therapeutics 53 (11) (2021)
Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Kouji Joko, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hiroyuki Kimura, Hitoshi Yagisawa, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Hideo Yoshida, Yasushi Uchida, Toshifumi Tada, Shinichiro Nakamura, Satoshi Yasuda, Hidenori Toyoda, Stephen Caldwell, Namiki Izumi
Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus. Hepatology communications (2021)
Abdul M Majzoub, Tarek Nayfeh, Abbey Barnard, Nagambika Munaganuru, Shravan Dave, Siddharth Singh, Mohammad Hassan Murad, Stephen Caldwell
Systematic review with network meta-analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH. Alimentary pharmacology & therapeutics 54 (7) (2021)
Hirokazu Takahashi, Yuichiro Eguchi, Masato Yoneda, Kento Imajo, Nobuharu Tamaki, Hideki Suganami, Toshiaki Nojima, Ryohei Tanigawa, Masakazu Iizuka, Yuki Iida, Stephen Caldwell
Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), versus placebo in patients with non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 54 (10) (2021)
Jung Gil Park, Jinho Jung, Kritin K Verma, Min-Kyu Kang, Egbert Madamba, Scarlett Lopez, Aed Qas Yonan, Amy Liu, Ricki Bettencourt, Claude Sirlin, Stephen Caldwell
Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 53 (9) (2021)
Xiao-Jing Zhang, Yan-Xiao Ji, Xu Cheng, Yanjie Cheng, Hailong Yang, Junyong Wang, Ling-Ping Zhao, Yong-Ping Huang, Dating Sun, Hui Xiang, Li-Jun Shen, Peng-Long Li, Jun-Peng Ma, Rui-Feng Tian, Juan Yang, Xinxin Yao, Hai-Bo Xu, Rufang Liao, Li Xiao, Peng Zhang, Xin Zhang, Guang-Nian Zhao, Xi Wang, Man-Li Hu, Song Tian, Juan Wan, Jingjing Cai, Xin-Liang Ma, Qingbo Xu, Yibin Wang, Rhian M Touyz, Peter P Liu, Stephen Caldwell, Zhi-Gang She, Hong Liang Li
A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques. Science translational medicine 13 (624) (2021)
Jessica L Petrick, Andrea A Florio, Stephen Caldwell, Katherine A McGlynn
Have incidence rates of liver cancer peaked in the United States? Cancer 126 (13) (2020)
Rish K Pai, Brian G Feagan, Claire E Parker, Vipul Jairath, Stephen Caldwell
Editorial: evolving histological assessment of NASH. Authors' reply. Alimentary pharmacology & therapeutics 50 (11-12) (2020)
Nobuharu Tamaki, Masayuki Kurosaki, Stephen Caldwell, Namiki Izumi
Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases. Annals of laboratory medicine 41 (1) (2020)
Jinho Jung, Rohan R Loomba, Kento Imajo, Egbert Madamba, Sanil Gandhi, Ricki Bettencourt, Seema Singh, Carolyn Hernandez, Mark A Valasek, Cynthia Behling, Lisa Richards, Katie Fowler, Claude B Sirlin, Hirokazu Takahashi, Stephen Caldwell
MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis. Gut 70 (10) (2020)
Stephen Caldwell, Brent A Neuschwander-Tetri, Arun Sanyal, Naga Chalasani, Anna Mae Diehl, Norah A Terrault, Kris Kowdley, Srinivasan Dasarathy, David Kleiner, Cynthia Behling, Joel Lavine, Mark Van Natta, Michael Middleton, James Tonascia, Claude Sirlin, null null
Multicenter Validation of Association Between Decline in MRI-PDFF and Histologic Response in NASH. Hepatology (Baltimore, Md.) 72 (4) (2020)
Stephen Caldwell, Lei Ling, Duy M Dinh, Alex M DePaoli, Hsiao D Lieu, Stephen A Harrison, Arun J Sanyal
The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in NASH. Hepatology (Baltimore, Md.) 73 (1) (2020)
Cyrielle Caussy, Jen-Chieh Chuang, Andrew Billin, Tao Hu, Ya Wang, G Mani Subramanian, C Stephen Djedjos, Robert P Myers, Edward A Dennis, Stephen Caldwell
Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis. Therapeutic advances in gastroenterology 13 (2020)
Daniel Q Huang, Hashem E El-Serag, Stephen Caldwell
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nature reviews. Gastroenterology & hepatology 18 (4) (2020)
Stephen Caldwell, Robert J Wong, Jeremy Fraysse, Sanatan Shreay, Suying Li, Stephen Harrison, Stuart C Gordon
Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data. Alimentary pharmacology & therapeutics 51 (11) (2020)
Gordon P Watt, Isela de la Cerda, Jen-Jung Pan, Michael B Fallon, Laura Beretta, Stephen Caldwell, Miryoung Lee, Joseph B McCormick, Susan P Fisher-Hoch
Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population-Based Study of Mexican Americans. Hepatology communications 4 (12) (2020)
Stephen Caldwell, Robert Wong, Jeremy Fraysse, Sanatan Shreay, Suying Li, Stephen Harrison, Stuart C Gordon
Editorial: how widespread and serious is non-alcoholic fatty liver disease in the real world? Authors' reply. Alimentary pharmacology & therapeutics 51 (11) (2020)
Elizabeth C Verna, Marina Serper, Jaime Chu, Kathleen Corey, Oren K Fix, Karen Hoyt, Kimberly A Page, Stephen Caldwell, Ming Li, Gregory T Everson, Michael W Fried, Guadalupe Garcia-Tsao, Norah A Terrault, Anna S Lok, Raymond T Chung, Rajender K Reddy
Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation. Hepatology (Baltimore, Md.) 72 (5) (2020)
Saumya Jayakumar, Stephen Caldwell
Letter: probiotics? Yes, but which ones? Authors' reply. Alimentary pharmacology & therapeutics 50 (8) (2020)
Björn Carlsson, Daniel Lindén, Gabriella Brolén, Mathias Liljeblad, Mikael Bjursell, Stefano Romeo, Stephen Caldwell
Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis. Alimentary pharmacology & therapeutics 51 (12) (2020)
Morten Asser Karsdal, Samuel Joseph Daniels, Signe Holm Nielsen, Cecilie Liv Bager, Daniel Guldager Kring Rasmussen, Stephen Caldwell, Rambabu Surabattula, Ida Falk Villesen, Yi Luo, Diane Shevell, Natasja S Gudmann, Mette Juul Nielsen, Jacob George, Rose Christian, Diana J Leeming, Detlef Schuppan
Collagen biology and non-invasive biomarkers of liver fibrosis. Liver international : official journal of the International Association for the Study of the Liver 40 (4) (2020)
Stephen Caldwell, Leon A Adams
Advances in non-invasive assessment of hepatic fibrosis. Gut 69 (7) (2020)
Saumya Jayakumar, Stephen Caldwell
Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications. Alimentary pharmacology & therapeutics 50 (2) (2019)
Mazen Noureddin, Stephen Caldwell
Editorial: role of leucine-metformin-sildenafil combination in the treatment of nonalcoholic fatty liver disease (NAFLD). Alimentary pharmacology & therapeutics 48 (3) (2019)
Rish K Pai, David E Kleiner, John Hart, Oyedele A Adeyi, Andrew D Clouston, Cynthia A Behling, Dhanpat Jain, Sanjay Kakar, Mayur Brahmania, Lawrence Burgart, Kenneth P Batts, Mark A Valasek, Michael S Torbenson, Maha Guindi, Hanlin L Wang, Veeral Ajmera, Leon A Adams, Claire E Parker, Brian G Feagan, Stephen Caldwell, Vipul Jairath
Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials. Alimentary pharmacology & therapeutics 50 (10) (2019)
Igor Maricic, Idania Marrero, Akiko Eguchi, Ryota Nakamura, Casey D Johnson, Suryasarathi Dasgupta, Carolyn D Hernandez, Phirum Sam Nguyen, Austin D Swafford, Rob Knight, Ariel E Feldstein, Stephen Caldwell, Vipin Kumar
Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis. Journal of immunology (Baltimore, Md. : 1950) 201 (10) (2018)

Stephen Caldwell.css-eqlu8i{font-size:small;padding-left:4px;} (Rohit Loomba, R Loomba)

Publication Activity (10 Years)

Top Topics

Top Venues

Stephen Caldwell (Rohit Loomba, R Loomba)